# Liminatus Pharma, Inc.: Form SCHEDULE 13D, filed May 8, 2025

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: SCHEDULE 13D
- Filed: 2025-05-08
- Accepted by EDGAR: May 8, 2025, 16:21 ET
- Period: not reported
- Accession: 0001200876-25-000020
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000120087625000020/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000120087625000020/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000120087625000020/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001200876-25-000020. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.
